SUR2/ABCC9 Polyclonal antibody

SUR2/ABCC9 Polyclonal Antibody for WB, ELISA
Cat No. 13599-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human, mouse

应用

WB, ELISA

ABC37, ABCC9, CMD1O, Sulfonylurea receptor 2, SUR2, SUR2/ABCC9

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inmouse heart tissue, mouse skeletal muscle tissue, unboiled mouse heart tissue

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

13599-1-AP targets SUR2/ABCC9 in WB, ELISA applications and shows reactivity with human, mouse samples.

经测试应用 WB, ELISA Application Description
经测试反应性 human, mouse
免疫原 SUR2/ABCC9 fusion protein Ag4536 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 ATP-binding cassette, sub-family C (CFTR/MRP), member 9
别名 ABC37, ABCC9, CMD1O, Sulfonylurea receptor 2, SUR2, SUR2/ABCC9
计算分子量 1549 aa, 174 kDa
观测分子量174 kDa
GenBank蛋白编号BC033804
基因名称 SUR2/ABCC9
Gene ID (NCBI) 10060
RRIDAB_3085419
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDO60706
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

ABCC9, also known as SUR2, belongs to the ABC transporter superfamily. ABCC9 is a subunit of ATP-sensitive potassium channels (KATP), forming cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation (PMID: 9831708). ABCC9 is thought to form ATP-sensitive potassium channels in cardiac, skeletal, vascular, and non-vascular smooth muscle. Defects in ABCC9 cause dilated cardiomyopathy 10 and familial atrial fibrillation type 12 (ATFB12)(PMID: 15034580,17245405).

实验方案

Product Specific Protocols
WB protocol for SUR2/ABCC9 antibody 13599-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...